I have never been more ashamed of the leadership of my country.
https://www.lifesitenews.com/news/he...etal-cell-line
OTTAWA, May 19, 2020 (LifeSiteNews) – A Canadian vaccine watchdog group says Canada’s approval of a human clinical trial of a Chinese coronavirus vaccine made from aborted fetal cell lines should “be a concern” for everyone and that rushing a vaccine to market could do more harm than good.
Pro-abortion Prime Minister Justin Trudeau announced Saturday that Health Canada approved the coronavirus vaccine Ad5-nCoV to be used in human clinical trials.
The vaccine candidate Ad5-nCoV uses the HEK293 cell line that LifeSiteNews reported last week is made from fetal cells harvested from an aborted baby decades ago. The HEK293 cell line was developed and is owned by Canada’s National Research Council (NRC).
On May 12, the NRC announced a collaboration with the Chinese firm CanSino Biologics Inc. (CanSinoBIO) to test and develop Ad5-nCoV in Canada. The trial vaccine Ad5-nCoV was co-developed by the Beijing Institute of Biotechnology and CanSinoBIO and has already been used in initial human trials since mid-March in China.
The clinical trials for Ad5-nCoV will be taking place at the Canadian Centre for Vaccinology at Dalhousie University, which is in Halifax. A total of 600 people will be needed for the trial, according to a CBC report, that will be done in phases.
Pro-abortion Prime Minister Justin Trudeau announced Saturday that Health Canada approved the coronavirus vaccine Ad5-nCoV to be used in human clinical trials.
The vaccine candidate Ad5-nCoV uses the HEK293 cell line that LifeSiteNews reported last week is made from fetal cells harvested from an aborted baby decades ago. The HEK293 cell line was developed and is owned by Canada’s National Research Council (NRC).
On May 12, the NRC announced a collaboration with the Chinese firm CanSino Biologics Inc. (CanSinoBIO) to test and develop Ad5-nCoV in Canada. The trial vaccine Ad5-nCoV was co-developed by the Beijing Institute of Biotechnology and CanSinoBIO and has already been used in initial human trials since mid-March in China.
The clinical trials for Ad5-nCoV will be taking place at the Canadian Centre for Vaccinology at Dalhousie University, which is in Halifax. A total of 600 people will be needed for the trial, according to a CBC report, that will be done in phases.
https://www.lifesitenews.com/news/he...etal-cell-line
Comment